Current options and new developments in the treatment of haemophilia. - Wikidata - awgldk - TriplyDB

Current options and new developments in the treatment of haemophilia.

Current options and new developments in the treatment of haemophilia.

http://www.wikidata.org/entity/Q37841547

about

Gene therapy for haemophilia Gene therapy for haemophilia The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells.The history and evolution of the clinical effectiveness of haemophilia type a treatment: a systematic review.Plasma exchange and immunosuppressive therapy in a case of mild haemophilia A with inhibitors and a life-threatening lower limb haemorrhage.Octocog alfa, antihaemophilic factor (recombinant), plasma/albumin free method (Advate®): a review of its use in the management of patients with haemophilia A.Advances in the treatment of inherited coagulation disorders.Long-term liver-related morbidity and mortality related to chronic hepatitis C virus infection in Swedish patients with inherited bleeding disorders.Difficult encounters with a hemophilic patient: the inner perspective of physicians.Gene Therapy for Hemophilia: Progress to Date.Platelet-Targeted Gene Therapy for Hemophilia.

P2860

Q24187977-18E87934-ED0A-4D66-B3F2-471443371DAE Q24202755-14300F1D-A2F3-4FA0-8DD8-F04CA10B8AF5 Q36675079-12D85D83-8761-46F1-AFB1-463C91838A77 Q36897565-5B8F5932-1A25-4362-8976-9093B20A4EDA Q37489033-B274E560-712E-4E5D-B280-1CC38CEF6832 Q37578173-25223B80-E0FF-40E3-851F-FA199012F476 Q37588914-26137C1A-FF2F-40C8-A463-2457C5A4A21D Q38008021-4280B359-AD33-4CD4-B3F9-E7FBCA1E8DE0 Q38100271-AC87DDA2-03D9-49C5-89DA-F1F8E7BB4F91 Q39321649-B9972A52-77B9-4546-AD05-7E8081ADFF04 Q45855372-C972351C-4F38-471E-85EC-2F65FA356FA9 Q45874307-ADDBE6CF-343E-41A1-9710-A1D2C4669508 Q54975244-9D526013-0590-47A3-9BC9-1E8E29727A94

P2860

Current options and new developments in the treatment of haemophilia.

http://www.wikidata.org/entity/Q37841547

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current options and new developments in the treatment of haemophilia.

@en

Current options and new developments in the treatment of haemophilia.

@nl

type

label

Current options and new developments in the treatment of haemophilia.

@en

Current options and new developments in the treatment of haemophilia.

@nl

prefLabel

Current options and new developments in the treatment of haemophilia.

@en

Current options and new developments in the treatment of haemophilia.

@nl

P1433

Q37841547-4F388136-66AF-45E8-9BE9-CBA45EB210C3

P1476

Q37841547-3BAF5C39-1503-434B-8BB6-72047707FEDF

P2093

Q37841547-0859785F-7B90-4BD7-AE0A-9269F85CFDAF

Q37841547-8E104096-97EA-43AA-97F1-A31F6F8FC4B2

P2860

Q37841547-07CAF3CC-455F-4B2A-89B5-C2BF9D91DC78

Q37841547-0C6FA801-9717-4957-B526-FB7E17458313

Q37841547-0D410F5B-F1F0-48FB-B716-DB424CC56B1B

Q37841547-12CADF04-46CD-4194-9086-FBADF7133CD4

Q37841547-16AF4DC9-80CE-4ACB-B902-80C29A4829C9

Q37841547-1C9D6697-22A4-4254-809F-0AD8CCC30C90

Q37841547-2E055157-26A6-44BA-A1B9-4939B47A8A46

Q37841547-2EDA8177-F590-4457-8065-B944DA172BD0

Q37841547-3516F108-433D-491E-882A-8DD57DF0C24E

Q37841547-355CCD36-C071-4902-A191-BD7336FB0A20

P2888

Q37841547-1F62F8FD-2BF5-4961-8C0C-276B5F8FA70B

P304

Q37841547-B6C62F37-F0E8-4627-99A4-2D6A66327FE1

P31

Q37841547-E51953FA-6B91-4EAC-BFE1-29DC3F4157AE

P356

Q37841547-ABEBBA18-73B2-4126-AD4D-14006B92CAD5

P433

Q37841547-BDE9A3B0-360F-49D5-84C7-9D9D73657018

P478

Q37841547-E5E46D22-960A-4DEC-B9D6-CD8B4DD77E7E

P577

Q37841547-5AE6196B-6624-47D2-BDCD-BEAA05604A51

P6179

Q37841547-95D4783C-DF73-4104-8633-5AA1BE4C4F65

P698

Q37841547-3F58A0C7-40CE-46BD-8A0A-FDE881437BEC

P921

Q37841547-AB6CCA9D-A2B7-49A4-B5BA-A01DB0C66217

P356

11585340-000000000-00000

P1433

P1476

Current options and new developments in the treatment of haemophilia.

@en

P2093

Michael Recht

http://www.w3.org/2001/XMLSchema#string

Trisha Wong

http://www.w3.org/2001/XMLSchema#string

P2860

The tertiary structure and domain organization of coagulation factor VIII

Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex

Peptide and protein PEGylation: a review of problems and solutions

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

Molecular cloning of a cDNA encoding human antihaemophilic factor

Treatment of congenital and acquired hemophilia patients by extracorporeal removal of antibodies to coagulation factors: a review of US clinical studies 1987-1990. Hemophilia Study Group.

Inhibitor antibodies to factor VIII and factor IX: management.

Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers.

Molecular cloning of the gene for human anti-haemophilic factor IX.

P2888

11585340-000000000-00000

P304

305-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11585340-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017148388

http://www.w3.org/2001/XMLSchema#string

P698

21319868

http://www.w3.org/2001/XMLSchema#string

P921